Rapport Therapeutics (RAPP) Change in Account Payables (2023 - 2026)
Rapport Therapeutics (RAPP) posted quarterly Change in Account Payables of $2.3 million for Q1 2026, up 1145.95% year-over-year from $185000.0 in Q1 2025, and up 95.67% quarter-over-quarter from $1.2 million in Q4 2025.
Powered by 
Analysis
Rapport Therapeutics (RAPP) Change in Account Payables (2023 - 2026) Analysis & Trends
Rapport Therapeutics (RAPP) has reported Change in Account Payables for 4 consecutive years, with $2.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables rose 1145.95% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $4.3 million (up 345.53% YoY), while the FY2025 annual figure was $2.2 million, up 740.17% from the prior year.
- Change in Account Payables grew to $2.3 million in Q1 2026 per RAPP's latest filing, from $1.2 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.3 million in Q1 2026 and bottomed at -$1.1 million in Q1 2024.
- Historically, Change in Account Payables has averaged $502909.1 across 4 years, with a median of $633000.0 in 2023.
- Annual changes were most pronounced in 2025 — Change in Account Payables tumbled 489.13% — and 2026, when it jumped 1145.95%.
- Rapport Therapeutics' Change in Account Payables stood at $725000.0 in 2023, then dropped by 10.62% to $648000.0 in 2024, then soared by 81.79% to $1.2 million in 2025, then surged by 95.67% to $2.3 million in 2026.
- Business Quant data shows RAPP's Change in Account Payables at $2.3 million in Q1 2026, $1.2 million in Q4 2025, and -$179000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -8.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 5.03 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Rapport Therapeutics | 2.17 Bn | 2.17 Bn | - | -3.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.68 Mn |
| Mar 31, 2026 | 2.31 Mn |
| Dec 31, 2025 | 1.18 Mn |
| Sep 30, 2025 | -179,000.00 |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 185,000.00 |
| Dec 31, 2024 | 648,000.00 |
| Sep 30, 2024 | 46,000.00 |
| Jun 30, 2024 | 94,000.00 |
| Mar 31, 2024 | -1.13 Mn |
| Dec 31, 2023 | 725,000.00 |
| Sep 30, 2023 | 633,000.00 |